SILODOSIN | A204793 | HETERO LABS LTD UNIT V
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Kissei Pharmaceutical Co. Ltd. et al v. Hetero USA Inc., et al. 1 patentANDA 204793silodosin | D. Del. | 2013-06-17 | Terminated 2015-01-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.3163
per ea
Lowest NADAC/Unit
$0.2903
per ea
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 31722063630SILODOSIN 8 MG CAPSULE | $0.3163 | EA | Generic | — | 2026-06-17 |
| 31722063690SILODOSIN 8 MG CAPSULE | $0.3163 | EA | Generic | — | 2026-06-17 |
| 31722063530SILODOSIN 4 MG CAPSULE | $0.2903 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.